SQUAWK/NEWS
Account
Theme
Account
Menu
Live News NEWS FLASH L impact

BRIEF — Oryzon Gets New Patent Grants For Vafidemstat In Four Countries

Oct 15 (Reuters) — Oryzon Genomics SA: Receives New Patent Grants For Vafidemstat In Four Countries Granted Patents For Vafidemstat In Bpd In Korea And Philippines Granted New Zealand Patent For Vafidemstat In Aggression And Social Withdrawal Granted Mexican Patent For Vafidemstat In Autism Spectrum Disorder Vafidemstat U.s. Patent Valid Until At Least 2043, Non-u.s. Patents Valid Until 2040 Source text: Further company coverage: ORY.MC (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;)

ORY.MC